NorthWest Biotherapeutics Inc (NWBO)

[exwannabe]

Yes, I realize that Valiant owns Provenge (along with DNDN's tax loss carry forward). But since the latter was a separate add-on to the deal we know that VRX paid $15M for the TLCF (VTX upped the offer by $95M to get the TLCF, a throw away drug and $80M cash).

My point is that TLCFs are not worth all that much UNLESS one can start making a profit with the underlying asset.

I have no argument that it has value IF NWBO can succesfully comercialize DCVax. BUT it has little value elsewhere. and it is certainly not worth "at least $2 - $3/share alone" where this conversation started.

BTW: Wrt provenge sales, yeah they have been steady to slightly falling for years now. Given that DNDN was not even very close to a profit at the same level, I question if VTX is making more than pocket change off of it.

There are a hell of a lot of games one can play in with financing aquistions to make them look better. And we know VRX has had "issues" in this.

Worth $500M? Doubtfull, be we shall see (perhaps).